Connect

New office strengthens Connect's presence across San Diego's innovation corridors and expands access for founders, partners and community members.

Funding will support development of HepTol™, a liver-targeted mRNA-LNP platform designed to prevent disease progression in T1D patients

Annual event brings together research institutions, founders, investors and ecosystem leaders

Vayim, a San Diego medical technology company and Connect Springboard company, will use the investment to advance its minimally invasive technology for chronic rhinosinusitis (CRS).

Sesh, a San Diego precision immuno-oncology company and Connect Cool Company, will use the investment to advance commercialization of its blood-based liquid biopsy technology.

An early-stage fund investing at the intersection of health innovation, AI, and robotics - including devices, diagnostics, and AI-driven health with recent backing of UC San Diego-rooted surgical navigation company KatoMed.

The Connect Current brings forward candid, insight driven conversations with founders, investors, and ecosystem leaders, offering a clear view into how innovation is built, funded, and scaled across San Diego's evolving economy.

Bringing venture backed expertise and deep tech insight to strengthen San Diego's tech and defense ecosystem, advancing founder support, strategic partnerships, and capital access across emerging and dual use innovation sectors.

Highlighting their impact on founders and the innovation ecosystem, Cait Kelly and Kylie Hovey transition from Connect to new roles in entrepreneurship and marketing, continuing to shape San Diego's growing community of innovators.

Bringing expertise across research, policy, and venture to enhance San Diego's Life Science Ecosystem